Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3029612	s-listab	— (—)	94	126	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other maternal disorders predominantly related to pregnancy

6.68

17.10

1.3

1.4

—

False labour

8.12

15.54

1.3

—

Maternal care for other known or suspected fetal problems

8.01

14.34

1.4

1.3

—

Postpartum haemorrhage

6.25

12.89

1.4

1.3

—

Diabetes mellitus in pregnancy

5.77

12.49

1.4

—

Gestational diabetes (for exclusion)

4.42

12.03

1.4

1.3

—

Perineal laceration during delivery

5.68

10.72

1.3

—

Female infertility

5.82

10.49

1.2

1.4

—

Premature rupture of membranes

7.16

8.17

1.3

—

Female infertility, cervical, vaginal, other or unspecified origin

5.15

8.00

1.2

1.4

—

Special screening examination for infectious and parasitic diseases

7.80

7.83

1.4

1.2

—

Postpartum hemorraghe, all women as controls

3.78

7.75

1.4

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.56

7.62

1.4

—

Other obstetric conditions, not elsewhere classified

3.44

7.02

1.4

—

Postpartum haemorrhage due to anatomy

3.97

6.88

1.3

1.4

—

Follow-up examination after treatment for conditions other than malignant neoplasms

6.62

6.60

1.3

1.2

—

Medical treatment for female infertility

3.78

6.46

1.4

—

Complications of labour and delivery

3.82

6.29

1.1

1.3

—

Other abnormal products of conception

3.76

6.27

1.2

1.4

—

Pregnancy with abortive outcome

3.39

6.21

1.2

1.4

—

Haemorrhage in early pregnancy

5.77

6.14

1.3

1.5

—

Medical observation and evaluation for suspected diseases and conditions

4.83

6.07

1.4

1.2

—

Other disorders of amniotic fluid and membranes

7.06

5.81

1.5

1.3

—

Abnormal findings on antenatal screening of mother

6.86

5.73

1.4

1.5

—

Noninflammatory disorders of female genital tract

3.86

5.58

1.3

1.4

—

Postpartum hemorraghe, parous women as controls

3.06

5.52

1.4

—

Female infertility, associated with anovulation

7.08

5.43

1.3

1.4

—

Spontaneous abortion

3.46

5.40

1.4

—

Persons encountering health services for examination and investigation

4.46

5.24

1.3

1.2

—

Maternal care for other conditions predominantly related to pregnancy

5.28

5.12

1.5

—

General examination and investigation of persons without complaint and reported diagnosis

4.35

4.88

1.3

1.2

—

Excessive vomiting in pregnancy

11.45

4.78

1.6

1.4

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.90

4.66

1.3

—

Symptoms and signs involving the digestive system and abdomen

2.93

4.62

1.4

1.3

—

Obesity due to excess calories

3.21

4.60

1.2

1.4

—

Infections of genitourinary tract in pregnancy

8.20

4.56

1.4

—

Other nutritional deficiencies

2.78

4.44

1.2

1.4

—

Other problems related to primary support group, including family circumstances

5.64

4.33

1.4

1.3

—

Procreative management

9.53

4.26

1.5

1.4

—

Obesity

2.72

4.08

1.2

1.4

—

Obesity and other hyperalimentation

2.71

4.07

1.2

1.4

—

Persons encountering health services in circumstances related to reproduction

7.58

4.04

1.2

1.4

—

Maternal care for known or suspected fetal abnormality and damage

4.98

3.89

1.4

1.3

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

4.11

3.83

1.4

1.3

—

Certain infectious and parasitic diseases

2.62

3.70

1.3

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.56

3.68

1.6

1.3

—

Nausea and vomiting

5.51

3.59

1.3

1.1

—

Polycystic ovarian syndrome, broad definition

3.62

3.49

1.3

1.4

—

Infections with a predominantly sexual mode of transmission

2.88

3.44

1.3

1.4

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.48

3.44

1.6

1.3

—

Endocrine, nutritional and metabolic diseases

2.43

3.40

1.2

1.4

—

Persons encountering health services in other circumstances, wide

2.52

3.35

1.3

—

Maternal care for known or suspected malpresentation of fetus

4.20

3.31

1.3

—

Abdominal and pelvic pain

2.57

3.30

1.4

1.3

—

Placenta praevia

8.59

3.26

1.3

—

Twin gestation

6.37

3.18

1.6

1.4

—

Multiple gestation

6.37

3.18

1.6

1.4

—

Exposure to other specified factors

2.50

3.15

1.4

1.3

—

Contraceptive management

7.01

3.14

1.3

1.4

—

Congenital malformations, deformations and chromosomal abnormalities

2.37

2.98

1.5

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.27

2.93

1.4

1.3

—

Depression or dysthymia

2.86

2.75

1.3

—

Other sexually transmitted chlamydial diseases

5.01

2.72

1.4

1.3

—

L02BG Aromatase inhibitors

5.99

2.69

1.2

1.3

—

Myalgia

4.21

2.67

1.4

—

Preterm labour and delivery

4.21

2.67

1.5

1.3

—

Soft tissue disorders

2.06

2.62

1.3

1.4

—

Endometriosis of pelvic peritoneum

4.77

2.61

1.3

1.4

—

Failed induction of labour

4.68

2.59

1.3

1.4

—

Symptoms and signs involving the urinary system

2.86

2.58

1.2

1.3

—

Postpartum haemorrhage due to retained placenta

2.86

2.54

1.3

1.4

—

Labour and delivery complicated by fetal stress [distress]

2.75

2.52

1.4

1.3

—

Medicines for HER+ breast cancer

4.42

2.47

1.1

1.3

—

Congenital malformations, deformations and chromosomal abnormalities

2.25

2.44

1.4

1.3

—

Pain (limb, back, neck, head abdominally)

2.59

2.44

1.4

1.2

—

Excessive, frequent and irregular menstruation

2.74

2.39

1.3

1.4

—

Other sexually transmitted chlamydial diseases

3.64

2.36

1.4

1.3

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

3.03

2.35

1.5

1.2

—

Obesity, other/unspecified

2.82

2.34

1.2

1.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.09

2.34

1.4

1.2

—

Examination and observation for other reasons

3.21

2.31

1.5

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.42

2.21

1.4

—

Tonsillectomy and adenotomy

2.05

2.18

1.5

1.3

—

Polycystic ovarian syndrome

3.69

2.15

1.3

1.4

—

Fissure and fistula of anal and rectal regions

4.29

2.15

1.0

1.3

—

Haemorrhoids and perianal venous thrombosis

4.28

2.14

1.3

—

Congenital malformations of genital organs

4.26

2.14

1.2

1.4

—

Any mental disorder

2.09

2.11

1.4

1.3

—

Maternal care for known or suspected abnormality of pelvic organs

3.06

2.08

1.2

1.3

—

Codes for special purposes

2.32

2.03

1.5

1.3

—

Provisional assignment of new diseases of uncertain etiology

2.32

2.03

1.5

1.3

—

Dysplasia of cervi uteri

2.96

2.03

1.7

1.4

—

Hypothyroidism and >3 levothyroxin purchases

2.45

2.00

1.3

—

Hypothyroidism, levothyroxine purchases

2.45

2.00

1.3

—

Hypothyroidism (congenital or acquired)

2.45

2.00

1.3

—

Anxiety disorders, excluding more controls

2.17

1.99

1.6

1.3

—

Inflammatory diseases of female pelvic organs

2.00

1.98

1.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

3.01

1.94

1.3

—

Colonic or urogenital fistula

3.75

1.93

1.0

1.3

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.98

1.92

1.5

1.2

—

Infections with a predominantly sexual mode of transmission

2.07

1.92

1.3

1.4

—

Chronic diseases of tonsils and adenoids

2.03

1.91

1.5

1.3

—

Neurological diseases, wide definition

2.51

1.87

1.3

—

Ectopic pregnancy

3.53

1.83

1.3

1.4

—

Certain infectious and parasitic diseases

2.26

1.79

1.4

—

Epilepsy

3.04

1.79

1.3

—

Acetic acid derivatives and related substances

3.30

1.76

1.4

1.2

—

Psychiatric diseases

2.00

1.75

1.3

—

Ovarian dysfunction

2.92

1.72

1.3

1.4

—

Oedema, not elsewhere classified

3.29

1.72

1.5

1.3

—

GASTRO-related operations

1.89

1.69

1.4

1.3

—

Any gastric operation

1.89

1.69

1.4

1.3

—

Unspecified mental disorder

0.00

1.68

0.0

1.3

—

Injuries to the hip and thigh

2.88

1.68

1.3

1.2

—

Polycystic ovarian syndrome, consortium definition

1.83

1.67

1.3

1.4

—

Other congenital malformations

3.16

1.66

1.5

1.3

—

Antepartum haemorrhage, not elsewhere classified

3.57

1.61

1.4

—

Medical abortion

2.03

1.57

1.4

—

Acute upper respiratory infections

1.83

1.54

1.5

1.3

—

Inflammatory disease of uterus

2.59

1.51

1.4

1.2

—

5-aminosalicylic acid

2.86

1.50

1.2

—

Long labour

2.49

1.49

1.3

—

Intestinal infectious diseases

1.78

1.49

1.4

1.3

—

Intestinal infectious diseases

1.80

1.45

1.4

1.3

—

Neurotic, stress-related and somatoform disorders

1.80

1.44

1.7

1.3

—

Anxiety disorders

1.79

1.42

1.7

1.3

—

Other disorders of urethra and urinary system

1.94

1.40

1.1

1.4

—

Other arrhythmias

2.22

1.38

1.5

1.3

—

Caries of dentine, including avohilmo

2.11

1.36

1.3

1.4

—

Bacterial infection, other or unspecified

2.60

1.34

1.2

1.3

—

Migraine without aura and triptan purchases

0.00

1.34

0.0

1.3

—

Parasetamol

1.79

1.33

1.3

1.4

—

Migraine without aura

0.00

1.32

0.0

1.4

—

Kela-code for severe mental illness

0.00

1.32

0.0

1.3

—

Sulfasalazine

2.50

1.30

1.3

—

Persons with potential health hazards related to communicable diseases

1.90

1.30

1.4

1.3

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2.78

1.28

1.2

1.3

—

Diseases of the musculoskeletal system and connective tissue

1.88

1.28

1.3

—

Personal history of other diseases and conditions

2.77

1.28

1.6

1.2

—

Other soft tissue disorders, not elsewhere classified

1.71

1.27

1.4

—

Vasomotor and allergic rhinitis

2.09

1.27

1.6

1.3

—

IBD patients in KELA-register

2.40

1.24

1.2

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.70

1.24

1.8

1.3

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2.69

1.24

1.8

1.3

—

Genitourinary diseases

2.18

1.22

1.3

—

Irregular menses

1.77

1.19

1.3

1.4

—

Inflammatory bowel disease, strict (require KELA)

2.31

1.18

1.2

1.3

—

Acute sinusitis

1.88

1.17

1.4

1.2

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.79

1.17

1.5

1.4

—

Other reaction to severe stress, and adjustment disorders

1.93

1.16

1.5

1.2

—

Poor fetal growth

2.05

1.15

1.3

1.4

—

Recurrent or chronic depression

2.08

1.15

1.4

1.3

—

Disease of hard tissues of teeth, NOS

2.44

1.14

1.3

—

KRA_PSY_EATING, excluding more controls

2.49

1.14

1.0

1.3

—

External causes of morbidity and mortality

1.79

1.13

1.4

1.3

—

Pre-eclampsia or poor fetal growth

1.84

1.12

1.4

—

Contact with and exposure to communicable diseases

1.84

1.11

1.3

1.4

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.99

1.11

1.5

1.3

—

Injury, poisoning and certain other consequences of external causes

1.86

1.10

1.4

1.3

—

Acute pharyngitis

2.36

1.08

1.4

1.2

—

Endometriosis ASRM stages 1,2

2.19

1.08

1.3

1.4

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.65

1.07

1.4

1.3

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.73

1.07

1.4

1.3

—

Caries of enamel

1.67

1.06

1.2

1.4

—

Covid-19 suspected case

2.12

1.05

1.6

1.2

—

Dental caries, including avohilmo

2.00

1.05

1.2

1.5

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.62

1.04

1.3

1.4

—

Bronchitis

1.60

1.04

1.6

1.3

—

Prolonged pregnancy

2.30

1.03

1.0

1.3

—

Ulcerative colitis

2.27

1.03

1.2

1.3

—

Autoimmune diseases

1.59

1.03

1.2

1.4

—

Allergic rhinitis

1.93

1.02

1.6

1.2

—

Mood disorders, excluding more controls

1.74

1.02

1.4

1.3

—

Pain in joint

1.91

1.01

1.6

1.2

—

Cholecystectomy

1.89

1.01

1.4

1.3

—

Depression

1.62

1.00

1.4

—

Chronic sinusitis

2.00

0.99

1.4

1.3

—

Other puerperal infections

0.00

0.97

0.0

1.3

—

Other and unspecified tonsillitis

1.81

0.97

1.4

1.2

—

Used for control exclusion in common control thyroid runs

1.57

0.95

1.2

1.4

—

Cardiac arrhythmias

1.77

0.95

1.4

—

Hypothyroidism, strict autoimmune

1.64

0.93

1.3

1.4

—

Adverse effects, not elsewhere classified

2.22

0.93

1.7

1.2

—

Systemic connective tissue disorders

2.22

0.93

1.2

—

COPD/asthma/ILD related infections

1.58

0.92

1.3

—

COPD/asthma related infections

1.58

0.92

1.3

—

Persons encountering health services for specific procedures and health care

0.52

0.91

1.0

1.3

—

Hypothyroidism, other/unspecified

1.57

0.91

1.3

1.4

—

Selective serotonin reuptake inhibitors

1.58

0.89

1.4

1.2

—

Noninfective enteritis and colitis

1.90

0.88

1.1

1.3

—

Gastrointestinal diseases

1.67

0.87

1.4

1.3

—

All anxiety disorders

1.63

0.87

1.7

1.3

—

Bacterial infection, other or unspecified

2.03

0.87

1.2

—

Covid-19 confirmed case

2.00

0.87

1.3

—

Diseases of oral cavity, salivary glands and jaws

2.06

0.86

1.2

1.3

—

Acute upper respiratory infections of multiple and unspecified sites

1.62

0.86

1.6

1.3

—

Pain in limb

1.59

0.85

1.4

—

Open wound of head

1.93

0.84

1.5

1.2

—

Autoimmune diseases related-to ILD

1.60

0.83

1.3

—

Allergic asthma (mode)

1.89

0.82

1.5

1.3

—

Allergic asthma (mode), excluding more controls

1.89

0.82

1.5

1.3

—

Fall on same level

0.58

0.82

1.2

1.4

—

Excluding asthma or asthma-COPD overlap

1.63

0.81

1.2

1.3

—

Other pulmonary diagnosis

1.63

0.81

1.2

1.3

—

Injuries to the elbow and forearm

1.70

0.81

1.3

—

Anxiety (asthma-related co-morbidities)

1.62

0.81

1.8

1.3

—

Disorders of other endocrine glands

1.71

0.81

1.3

—

Coxibs

2.39

0.80

1.4

1.2

—

Meniscus derangement

0.00

0.79

0.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.82

0.79

1.3

—

Inflammatory bowel disease

1.82

0.79

1.2

1.3

—

Persons encountering health services in other circumstances

1.81

0.78

1.3

1.2

—

Propionic acid derivatives

2.29

0.78

1.0

1.2

—

Periapical abscess

1.76

0.76

1.5

1.2

—

COPD differential diagnosis

1.59

0.76

1.2

1.3

—

ILD differential diagnosis

1.59

0.76

1.2

1.3

—

Abnormalities of breathing

0.54

0.75

1.5

1.3

—

Gestational [pregnancy-induced] hypertension

1.69

0.75

1.3

1.4

—

Endometriosis

1.87

0.74

1.3

1.5

—

Other arthritis (FG)

2.08

0.74

1.4

1.2

—

Gingivitis and periodontal diseases

1.55

0.73

1.1

1.4

—

Symptoms and signs involving the circulatory and respiratory systems

1.46

0.73

1.4

1.3

—

Other viral diseases

1.84

0.73

1.3

—

Other heart diseases, wide

1.53

0.72

1.5

1.3

—

Deforming dorsopathies

2.00

0.72

1.4

1.2

—

Eating disorder

2.00

0.72

1.0

1.4

—

Mycoses

1.52

0.71

1.3

—

Pregnancy hypertension

1.58

0.70

1.4

—

Superficial injury of wrist and hand

1.92

0.70

1.2

1.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.73

0.70

1.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.49

0.70

1.4

1.3

—

Other viral diseases

1.57

0.70

1.2

1.4

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.71

0.70

1.3

—

Ovarian cyst

1.68

0.68

1.1

1.4

—

Pain in throat and chest

1.53

0.68

1.4

1.3

—

Sleep disorders

1.48

0.67

1.5

1.3

—

Injuries to the knee and lower leg

1.42

0.67

1.3

1.4

—

Peritonsillar abscess

1.79

0.66

1.6

1.3

—

Suicide or other Intentional self-harm

1.79

0.66

1.4

1.3

—

Eating disorders

1.78

0.66

1.0

1.3

—

Sciatica+with lumbago

1.61

0.66

1.7

1.3

—

Inflammatory bowel disease treatment related agents

1.42

0.65

1.4

1.3

—

Mood [affective] disorders

1.46

0.65

1.3

1.4

—

Depression medications

1.68

0.65

1.5

1.3

—

Mood disorders

1.46

0.65

1.3

1.4

—

Disorders of the thyroid gland

1.45

0.63

1.3

1.4

—

Other diseases of lip and oral mucosa

1.67

0.61

1.4

1.3

—

Other external causes of accidental injury

1.47

0.61

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.60

0.61

1.5

1.3

—

Other functional intestinal disorders

1.66

0.61

1.2

1.4

—

Nerve, nerve root and plexus disorders

0.61

0.60

1.1

1.4

—

Implicit viral Sepsis

0.00

0.60

0.0

1.3

—

Bacterial Sepsis

0.00

0.60

0.0

1.3

—

Other heart diseases

1.54

0.59

1.4

1.3

—

Other benign neoplasms of skin

0.00

0.59

0.0

1.2

—

Childhood asthma (age<16)

1.75

0.58

1.2

1.3

—

Childhood asthma (age<16), excluding more controls

1.75

0.58

1.2

1.3

—

Dental operations

1.71

0.58

1.2

1.6

—

Dermatophytosis

1.48

0.57

1.3

—

Dentofacial anomalies [including malocclusion]

1.44

0.57

1.3

1.4

—

Disorders of choroid and retina

1.64

0.56

1.0

1.2

—

1.39

0.54

1.4

1.3

—

All dysplastic lesions of the cervix uteri

1.51

0.54

1.7

1.4

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.50

0.54

1.7

1.4

—

Disorders of breast

1.49

0.54

1.2

1.4

—

Pollen allergy

1.56

0.53

1.2

1.3

—

Substance abuse, excluding more controls

1.55

0.53

1.3

—

Other and unspecified effects of external causes

1.54

0.53

1.7

1.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.54

0.53

1.3

—

Other bacterial diseases

1.44

0.53

1.1

1.3

—

Cholelithiasis

1.53

0.52

1.5

1.4

—

Neurological diseases

1.38

0.51

1.2

1.4

—

Diseases of the skin and subcutaneous tissue

1.38

0.51

1.3

1.4

—

Diseases of pulp and periapical tissues and dental caries

1.63

0.51

1.1

1.5

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.39

0.50

1.3

1.4

—

Candidiasis

1.46

0.50

1.3

1.2

—

Other diseases of upper respiratory tract

1.40

0.49

1.3

—

Triptan medication for migraine, min. 3 purchases

0.64

0.49

1.3

1.4

—

Asthma (only as main-diagnosis)

1.48

0.48

1.5

1.3

—

Childhood allergy (age < 16)

1.48

0.47

1.3

—

Cholelithiasis, broad definition with cholecystitis

1.50

0.47

1.5

1.4

—

1.48

0.47

1.6

1.3

—

Asthma (only as main-diagnosis), excluding more controls

1.46

0.46

1.5

1.3

—

Dental pulpitis, including avohilmo

1.35

0.46

1.5

1.3

—

Other antidepressants

1.37

0.45

1.4

1.2

—

Migraine

1.41

0.45

1.3

—

Other diseases of hard tissues of teeth

1.72

0.45

1.2

1.3

—

Accidents

1.37

0.43

1.4

1.3

—

Complications of medical and surgical care

1.44

0.42

1.3

—

Diseases of the respiratory system

1.47

0.42

1.3

—

Fenamates

0.00

0.42

0.0

1.2

—

Ischaemic heart disease, wide definition

0.00

0.42

0.0

1.1

—

Type1 diabetes, definitions combined, early onset

0.00

0.41

0.0

1.3

—

Mental disorders, not otherwise specified

0.00

0.41

0.0

1.3

—

Other specified and unspecified personality disorders

0.00

0.41

0.0

1.3

—

Allergic contact dermatitis

0.00

0.41

0.0

1.3

—

Pain in thoracic spine

0.00

0.41

0.0

1.2

—

Implicit viral Sepsis

0.00

0.41

0.0

1.2

—

Viral Sepsis

0.00

0.41

0.0

1.2

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.41

0.0

1.2

—

Cervical disc disorders

0.00

0.41

0.0

1.1

—

Other diseases of urinary system

1.34

0.41

1.2

1.4

—

L04AA Selective immunosuppressants

0.00

0.41

0.0

1.3

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.41

0.0

1.3

—

Type 1 diabetes, definitions combined

0.00

0.41

0.0

1.3

—

Sleep disorders (combined)

1.31

0.41

1.5

1.3

—

Use of hypnotics and sedatives

0.66

0.41

1.1

1.4

—

Impacted maxillary molar

0.00

0.40

0.0

1.4

—

Early lumbar disc prolapse, operated

0.00

0.40

0.0

1.2

—

Early lumbar disc prolapse operation

0.00

0.40

0.0

1.3

—

Superficial injury of ankle and foot

0.00

0.40

0.0

1.4

—

Cellulitis

0.00

0.40

0.0

1.3

—

Extrapyramidal and movement disorders

0.00

0.40

0.0

1.2

—

Menorrhagia

1.46

0.40

1.4

1.5

—

Implicit bacterial Sepsis

0.00

0.40

0.0

1.2

—

Cervicalgia

0.00

0.40

0.0

1.2

—

Generalized anxiety disorder

1.43

0.39

1.6

1.2

—

Poisoning by drugs, medicaments and biological substances

1.43

0.39

1.4

1.3

—

Viral infections characterized by skin and mucous membrane lesions

1.43

0.39

1.4

1.2

—

Other viral diseases, not elsewhere classified

1.42

0.39

1.2

1.3

—

Exclusions for E4_PCOS_BROAD

0.00

0.39

0.0

1.3

—

Fracture of shoulder and upper arm

0.00

0.39

0.0

1.3

—

Diseases of oesophagus, stomach and duodenum

0.70

0.38

1.3

1.4

—

Insomnia

1.32

0.38

1.6

1.3

—

Asthma/COPD (KELA code 203)

0.69

0.38

1.5

1.3

—

Osteopathies and chondropathies

1.37

0.37

1.2

1.3

—

Cystitis

1.32

0.36

1.3

1.4

—

Fall on same level involving ice and snow

1.36

0.34

1.3

—

Chronic apical periodontitis

0.75

0.34

1.4

1.3

—

Other disorders of skin and subcutaneous tissue

1.33

0.33

1.2

1.3

—

Migraine with aura

1.33

0.33

1.5

1.3

—

Disorders of conjunctiva

1.30

0.33

1.3

—

HSIL lesion of the cervix uteri

1.30

0.33

1.7

1.4

—

HSIL lesion of the cervix uteri, vagina or vulva

1.28

0.32

1.7

1.4

—

Mental and behavioural disorders due to psychoactive substance use

1.35

0.31

1.3

—

Asthma

1.34

0.31

1.5

1.3

—

Asthma (mode)

1.34

0.31

1.5

1.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.31

0.30

1.1

1.3

—

Diseases of the ear and mastoid process

1.24

0.30

1.3

1.4

—

Asthma, excluding more controls

1.33

0.30

1.5

1.3

—

Falls/tendency to fall

0.78

0.29

1.4

—

Asthma-related infections

1.22

0.28

1.6

1.3

—

Asthma, hospital admission 2, infections

1.22

0.28

1.6

1.3

—

Episodal and paroxysmal disorders

1.24

0.28

1.4

1.3

—

Exposure to unspecified factor

1.26

0.28

1.5

1.3

—

Type 2 diabetes, strict (exclude DM1)

1.33

0.28

1.3

1.4

—

Type 2 diabetes, definitions combined

1.33

0.28

1.3

1.4

—

Metabolic disorders

1.22

0.27

1.1

1.3

—

First line medication for Crohn's disease

1.22

0.27

1.5

1.3

—

Dislocation, sprain and strain of joints and ligaments of knee

1.21

0.26

1.4

1.3

—

Disorders of eyelid, lacrimal system and orbit

0.69

0.26

1.0

1.4

—

Biguanides

1.28

0.26

1.3

1.4

—

Other (not insulin) diabetes medications

1.32

0.26

1.3

1.4

—

Viral infections characterized by skin and mucous membrane lesions

1.27

0.26

1.4

1.3

—

Other dorsopathies, not elsewhere classified

0.79

0.25

1.5

1.3

—

Polyarthropathies

1.22

0.25

1.2

1.4

—

Headache

1.27

0.24

1.2

1.4

—

Opioids

1.21

0.24

1.4

1.3

—

Anaemias

1.36

0.24

1.4

1.2

—

Disorders of gallbladder, biliary tract and pancreas

1.29

0.23

1.5

1.3

—

Malaise and fatigue

1.30

0.23

1.2

1.4

—

Diseases of middle ear and mastoid

1.24

0.23

1.3

1.4

—

Diseases of pulp and periapical tissues, including avohilmo

0.80

0.23

1.3

—

Mental and behavioural disorders due to alcohol

1.26

0.22

1.4

1.3

—

Oral corticosteroids

1.22

0.22

1.4

1.3

—

Female genital prolapse

0.00

0.22

0.0

1.5

—

Arthropathies

1.20

0.22

1.4

1.3

—

Major coronary heart disease event excluding revascularizations

0.00

0.22

0.0

1.1

—

Angina pectoris

0.00

0.22

0.0

1.1

—

Heart failure,strict

0.00

0.22

0.0

1.1

—

Reimbursement for rheumatic diseases

1.21

0.22

1.6

1.3

—

Fitting and adjustment of other devices

0.00

0.21

0.0

1.2

—

All-cause Heart Failure

0.00

0.21

0.0

1.1

—

Heart failure, strict

0.00

0.21

0.0

1.1

—

Benign neoplasm: Colon

0.00

0.21

0.0

1.1

—

Other chronic obstructive pulmonary disease

0.00

0.21

0.0

1.1

—

COPD

0.00

0.21

0.0

1.1

—

Open bite

0.00

0.21

0.0

1.3

—

Mixed and other personality disorders

0.00

0.21

0.0

1.2

—

Adalimumab

0.00

0.21

0.0

1.3

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.2

—

Purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.3

—

Benign neoplasm of ovary

0.00

0.21

0.0

1.2

—

Glomerular diseases

0.00

0.21

0.0

1.1

—

Nasal polyp

0.00

0.21

0.0

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

1.3

—

Alcohol dependence

0.00

0.21

0.0

1.1

—

GI-bleeding

0.00

0.21

0.0

1.2

—

Asthma, unspecified (mode)

1.18

0.21

1.6

1.3

—

Implicit bacterial Sepsis

0.00

0.21

0.0

1.2

—

Other and unspecified mood [affective] disorders

0.00

0.21

0.0

1.2

—

Pruritus

0.00

0.21

0.0

1.3

—

Chalazion

0.00

0.21

0.0

1.3

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

0.21

0.0

1.1

—

Other diseases of the digestive system

0.00

0.21

0.0

1.2

—

Diseases of the eye and adnexa

0.81

0.21

1.1

1.4

—

COPD, hospital admissions

0.00

0.21

0.0

1.1

—

COPD, early/later onset

0.00

0.21

0.0

1.1

—

Coronary atherosclerosis

0.00

0.21

0.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

0.00

0.21

0.0

1.1

—

Rosacea

0.00

0.21

0.0

1.2

—

Injury of eye and orbit

0.00

0.21

0.0

1.3

—

Schizophrenia

0.00

0.21

0.0

1.2

—

Other diseases of blood and blood-forming organs, wide

0.00

0.21

0.0

1.2

—

Benign lipomatous neoplasm

0.00

0.21

0.0

1.2

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.21

0.0

1.3

—

Type 1 diabetes, strict definition

0.00

0.21

0.0

1.3

—

Hypertension, essential

1.26

0.20

1.0

1.3

—

Type 2 diabetes, definitions combined, including avohilmo

1.27

0.20

1.3

1.4

—

Fracture of forearm

1.25

0.20

1.3

—

Complications of the puerperium, not elsewhere classified

0.00

0.20

0.0

1.4

—

Second line medication for Crohn's disease

1.22

0.20

1.0

1.3

—

Speech and linguistic disorders

0.00

0.20

0.0

1.3

—

Other acute lower respiratory infections

1.22

0.20

1.3

—

Asthma, hospital admissions , main diagnosis only

1.23

0.19

1.5

1.3

—

Substance abuse

1.17

0.19

1.3

—

Autoimmune diseases excluding thyroid diseases

1.19

0.18

1.1

1.4

—

Transport accidents

1.20

0.18

1.3

—

Benign neoplasms

0.84

0.18

1.3

1.4

—

Other joint disorders

1.17

0.18

1.4

1.3

—

Disorders of skin appendages

1.17

0.17

1.4

1.3

—

Artrosis, including avohilmo

0.72

0.17

1.2

1.3

—

Other diseases of intestines

1.17

0.17

1.2

1.4

—

Asthma, including avohilmo

0.84

0.17

1.6

1.3

—

Excessive attrition of teeth

1.14

0.16

1.1

1.4

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.13

0.16

1.4

—

Influenza and pneumonia

1.17

0.16

1.2

1.4

—

Sleep apnoea, including avohilmo

0.74

0.16

1.2

1.4

—

Appendectomy

0.74

0.15

1.5

1.3

—

Other anxiety disorders

1.15

0.15

1.4

1.3

—

Temporomandibular joint disorders, including avohilmo

1.15

0.15

1.3

1.4

—

Pneumonia, organism unspecified

1.11

0.15

1.1

1.4

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.83

0.14

1.0

1.4

—

Complications of surgical and medical care, not elsewhere classified

0.82

0.14

1.3

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

0.81

0.14

1.4

—

Atopic dermatitis

0.83

0.14

1.1

1.4

—

Injuries to the ankle and foot

0.83

0.13

1.3

—

Codeine or tramadol medication

1.14

0.13

1.3

1.4

—

Conjunctivitis

1.16

0.12

1.4

—

Type 2 diabetes

1.17

0.12

1.3

1.4

—

Codeine

1.13

0.11

1.3

—

Finngen Rheumatological endpoints

1.14

0.11

1.4

1.3

—

Benzodiazepine use

1.13

0.10

1.6

1.3

—

Asthma, unspecified (mode), excluding more controls

1.17

0.10

1.6

1.3

—

Hypertensive diseases (excluding secondary)

1.12

0.10

1.0

1.3

—

Other and unspecified dermatitis

1.14

0.10

1.2

1.4

—

1.10

0.09

1.4

1.2

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.09

0.09

1.2

1.3

—

Disorders of synovium and tendon

1.07

0.09

1.0

1.4

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.13

0.09

1.2

1.4

—

Cardiovascular diseases

1.12

0.09

1.2

1.4

—

L04AX Other immunosuppressants

1.06

0.09

1.0

1.3

—

1.05

0.09

1.4

1.2

—

Diabetes, varying definitions

1.13

0.09

1.3

1.4

—

Dizziness and giddiness

1.08

0.09

1.0

1.4

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.07

0.08

1.3

—

Constipation

1.04

0.08

1.2

1.3

—

Solid cancers, helper endpoint

0.82

0.08

1.0

1.3

—

Sleep apnoea

0.83

0.08

1.2

1.4

—

Injuries to the shoulder and upper arm

0.82

0.08

1.0

1.3

—

Acute suppurative otitis media

0.83

0.08

1.2

1.4

—

Acute tubulo-interstitial nephritis

0.78

0.08

1.0

1.4

—

ILD medications: immunosuppressive drugs

0.79

0.08

1.0

1.4

—

Necrosis of pulp, including avohilmo

0.79

0.08

1.0

1.4

—

Symptoms and signs involving the skin and subcutaneous tissue

1.05

0.08

1.0

1.4

—

Any reimbursement code in KELA

0.89

0.08

1.2

1.4

—

Suppurative and unspecified otitis media

0.84

0.07

1.2

1.4

—

All kidney diseases

0.89

0.07

1.1

1.4

—

Allergic conjunctivitis

1.05

0.07

1.4

—

Diseases of appendix

0.86

0.07

1.4

1.3

—

Appendicitis, broad definition

0.87

0.07

1.4

1.3

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.89

0.07

1.2

1.4

—

Triptan medication for migraine, single purchase ok

0.89

0.07

1.2

1.4

—

Diabetes mellitus

1.11

0.07

1.3

1.4

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

0.89

0.06

1.1

1.4

—

Low back pain

0.90

0.06

1.2

1.3

—

Other specific joint derangements/joint disorders

0.90

0.06

1.5

1.3

—

Neoplasms

1.09

0.06

1.1

1.4

—

General symptoms and signs

1.09

0.06

1.1

1.4

—

Antihypertensive medication - note that there are other indications

1.09

0.05

1.4

—

Dermatitis and eczema

0.92

0.05

1.2

1.4

—

Chronic lower respiratory diseases

0.93

0.04

1.4

1.3

—

All pneumoniae

0.92

0.04

1.1

1.4

—

Pneumonias (Asthma/COPD co-morbidities)

0.92

0.03

1.1

1.4

—

Cardiovascular diseases (excluding rheumatic etc)

1.05

0.01

1.3

1.4

—

Asthma (diagnoses ohter than nonallergic)

1.06

0.00

1.5

1.3

—

Dorsalgia

0.95

0.00

1.5

1.3

—

Lower back pain or/and sciatica

1.05

0.00

1.5

1.3

—

Diabetes medication

1.05

0.00

1.3

1.4

—

Injuries to the head

0.99

0.00

1.4

1.3

—

Dorsopathies

0.97

0.00

1.6

1.3

—

Exclusions for E4_PCOS_CONSORTIUM

1.00

0.00

1.0

1.4

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.03

0.00

1.4

1.3

—

Any event in cancer register

1.01

0.00

1.3

1.4

—

Injuries to the wrist and hand

1.03

0.00

1.3

1.4

—

1.06

0.00

1.1

1.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.06

0.00

1.1

1.3

—

ILD medications

0.97

0.00

1.4

1.3

—

Nonspecific lymphadenitis

0.00

0.0

1.2

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

0.0

1.2

—

Hypoplasia of dental enamel , including avohilmo

0.00

0.0

1.0

—

Zoster [herpes zoster]

0.00

0.0

1.0

—

Other and unspecified polyneuropathies, also in other diseases

0.00

0.0

1.2

—

Bilateral sagittal split ramus osteotomy operation

0.00

0.0

1.2

—

Other congenital malformations of face and neck

0.00

0.0

1.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.0

1.2

—

severe traumatic brain injury, does not include concussion

0.00

0.0

1.2

—

Speech and linguistic disorders, excluding more controls

0.00

0.0

1.0

—

Other endocrine disorders

0.00

0.0

1.2

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.0

1.1

—

Certain disorders involving the immune mechanism

0.00

0.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.0

1.2

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.0

1.0

—

Cardiodefibrillation

0.00

0.0

1.0

—

Other disorders of the genitourinary system

0.00

0.0

1.1

—

Foreign body on external eye

0.00

0.0

1.2

—

Other and unspecified rosacea

0.00

0.0

1.1

—

Acute appendicitis

0.90

0.00

1.4

1.3

—

Event of undetermined intent

0.00

0.0

1.2

—

Complications of procedures, not elsewhere classified

0.93

0.00

1.3

1.4

—

Scar conditions and fibrosis of skin

0.00

0.0

1.2

—

Benign mammary dysplasia

0.00

0.0

1.1

—

Seborrhoeic keratosis

0.00

0.0

1.1

—

Benign neoplasm: Skin of trunk

0.00

0.0

1.2

—

Aortic valve malfunction, age under 60 years

0.00

0.0

1.2

—

Other infective otitis externa

0.00

0.0

1.2

—

Otalgia

0.00

0.0

1.2

—

Suppurative otitis media, unspecified

0.00

0.0

1.2

—

Dermatitis due to ingested food

0.00

0.0

1.2

—

Dystonia

0.00

0.0

1.0

—

Chronic iridocyclitis

0.00

-0.00

0.0

1.2

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.2

—

Polyneuropathies and other disorders of the peripheral nervous system

0.00

-0.00

0.0

1.1

—

Malignant melanoma

0.00

-0.00

0.0

1.2

—

Adjustment and management of implanted device

0.00

-0.00

0.0

1.1

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.2

—

Mixed disorders of conduct and emotions

0.00

-0.00

0.0

1.2

—

Algoneurodystrophy

0.00

-0.00

0.0

1.2

—

Other disorders of optic [2nd] nerve and visual pathways

0.00

-0.00

0.0

1.2

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

-0.00

0.0

1.2

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

1.1

—

Fracture of lumbar spine and pelvis

0.00

-0.00

0.0

1.1

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

1.1

—

Ptosis of eyelid

0.00

-0.00

0.0

1.2

—

Soft tissue disorders related to use, overuse and pressure

0.00

-0.00

0.0

1.1

—

Hidradenitis suppurativa

0.00

-0.00

0.0

1.2

—

Infective dermatitis

0.00

-0.00

0.0

1.0

—

Sarcoidosis

0.00

-0.00

0.0

1.1

—

Schizoaffective disorder

0.00

-0.00

0.0

1.1

—

Glaucoma suspect

0.00

-0.00

0.0

1.1

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.2

—

Episcleritis

0.00

-0.00

0.0

1.2

—

Other otitis externa (chronic)

0.00

-0.00

0.0

1.2

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.2

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.1

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.1

—

Specific development disorders of scholastic skills

0.00

-0.00

0.0

1.2

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

1.1

—

Cerebral palsy and other paralytic syndromes

0.00

-0.00

0.0

1.1

—

Maternal care for known or suspected disproportion

0.00

-0.00

0.0

1.2

—

Astigmatism

0.00

-0.00

0.0

1.3

—

Rash and other nonspecific skin eruption

0.00

-0.00

0.0

1.2

—

Hypertensive diseases

0.94

-0.00

1.0

1.3

—

Radiculopathy

0.00

-0.00

0.0

1.1

—

Other and unspecified injuries of ankle and foot

0.00

-0.00

0.0

1.2

—

Hyperprolactinaemia

0.00

-0.00

0.0

1.2

—

Other complications of surgical and medical care, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Myocardial infarction

0.00

-0.00

0.0

1.0

—

Achilles tendinitis

0.00

-0.00

0.0

1.1

—

Care involving dialysis

0.00

-0.00

0.0

1.2

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

-0.00

0.0

1.0

—

Restless leg syndrome

0.00

-0.00

0.0

1.1

—

Presence of cardiac and vascular implants and grafts

0.00

-0.00

0.0

1.1

—

0.00

-0.00

0.0

1.3

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.2

—

Desensitization to allergens

0.00

-0.00

0.0

1.3

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.2

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

1.2

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

1.2

—

Other and unspecified drugs and medicaments

0.00

-0.00

0.0

1.2

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

1.2

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

1.2

—

Foreign body or object entering through skin

0.00

-0.00

0.0

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

-0.00

0.0

1.3

—

Primary gonarthrosis, bilateral

0.00

-0.00

0.0

1.1

—

Exposure to other and unspecified inanimate mechanical forces

0.00

-0.00

0.0

1.2

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.2

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.2

—

Other and unspecified injuries of lower leg

0.00

-0.00

0.0

1.1

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

0.95

-0.00

1.3

—

Viral and other specified intestinal infections

1.00

-0.00

1.2

1.3

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

1.2

—

Benign neoplasm of other and unspecified endocrine glands

0.00

-0.00

0.0

1.1

—

Contusion of other and unspecified parts of foot

0.00

-0.00

0.0

1.3

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.2

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of head

0.00

-0.00

0.0

1.2

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.1

—

Benign neoplasm of meninges

0.00

-0.00

0.0

1.2

—

Acute appendicitis, no complications

0.90

-0.00

1.5

1.3

—

Other follicular disorders

0.00

-0.00

0.0

1.2

—

Tooth agenesis EXCLUDE clefts and syndromes

0.00

-0.00

0.0

1.3

—

Somnolence, stupor and coma

0.00

-0.00

0.0

1.2

—

Abnormal serum enzyme levels

0.00

-0.00

0.0

1.1

—

Cramp and spasm

0.00

-0.00

0.0

1.2

—

Dermatitis

0.94

-0.00

1.2

1.4

—

Non-ischemic cardiomyopathy

0.00

-0.00

0.0

1.1

—

Pacemaker

0.00

-0.00

0.0

1.1

—

Use of pramipexole

0.00

-0.00

0.0

1.1

—

LeFortI or BSSO operation

0.00

-0.00

0.0

1.2

—

Renal tubulo-interstitial diseases

0.92

-0.00

1.1

1.4

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.2

—

Nephropathy related operations

0.00

-0.00

0.0

1.2

—

L04AD Calcineurin inhibitors

0.00

-0.00

0.0

1.1

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Other osteochondropathies

0.00

-0.00

0.0

1.2

—

Glomerulonephritis

0.00

-0.00

0.0

1.2

—

Other disorders of ear

0.96

-0.00

1.2

1.3

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

-0.00

0.0

1.1

—

Ingrowing nail

0.00

-0.00

0.0

1.2

—

Lichen planus

0.00

-0.00

0.0

1.2

—

Other inflammatory liver diseases

0.00

-0.00

0.0

1.2

—

Suggestive for eosinophilic asthma

0.00

-0.00

0.0

1.2

—

Nail disorders

0.00

-0.00

0.0

1.3

—

Diseases of peritoneum

0.00

-0.00

0.0

1.2

—

Periodontitis

0.97

-0.00

1.0

1.3

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

-0.00

0.0

1.2

—

Malignant melanoma, including Hilmo

0.00

-0.00

0.0

1.2

—

Crossbite

0.00

-0.00

0.0

1.2

—

Infections of the skin and subcutaneous tissue

1.01

-0.00

1.2

1.4

—

Myocardial infarction, without ST-elevation

0.00

-0.00

0.0

1.0

—

Gastric ulcer

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Sigmoid colon

0.00

-0.00

0.0

1.2

—

Chronic suppurative otitis media, including avohilmo

0.00

-0.00

0.0

1.2

—

Other CVD

0.00

-0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.2

—

Dermatophytosis

0.00

-0.00

0.0

1.2

—

Vitreous haemorrhage

0.00

-0.00

0.0

1.2

—

Disorders of eyelid in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

1.2

—

Other inflammation of eyelid

0.00

-0.00

0.0

1.2

—

Persistent delusional disorders

0.00

-0.00

0.0

1.2

—

Conductive hearing loss, unspecified

0.00

-0.00

0.0

1.1

—

Nonsuppurative otitis media

0.96

-0.00

1.4

1.3

—

Other peripheral vertigo

0.00

-0.00

0.0

1.2

—

DVT of lower extremities

0.00

-0.00

0.0

1.1

—

Cerebral cysts

0.00

-0.00

0.0

1.2

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.2

—

Chronic laryngitis and laryngotracheitis

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.2

—

Lesion of ulnar nerve

0.00

-0.00

0.0

1.2

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.2

—

Other appendicitis

0.00

-0.00

0.0

1.1

—

Dissociative [conversion] disorders

0.00

-0.00

0.0

1.0

—

Agoraphobia

0.00

-0.00

0.0

1.1

—

Use of interferon beta-1a

0.00

-0.00

0.0

1.2

—

Other bacterial diseases

0.95

-0.00

1.1

1.4

—

Hypoglycaemia, other or unspecified

0.00

-0.00

0.0

1.2

—

Dialysis, with operation codes

0.00

-0.00

0.0

1.2

—

Gastroduodenal ulcer

0.00

-0.00

0.0

1.1

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Combinations of oral blood glucose lowering drugs

0.00

-0.00

0.0

1.0

—

COPD, hospital admission 2, with asthma infections

0.00

-0.00

0.0

1.0

—

Leiomyoma of uterus

1.01

-0.00

1.0

1.4

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

1.1

—

Immunodeficiencies

0.00

-0.00

0.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.1

—

Blepharochalasis

0.00

-0.00

0.0

1.2

—

Mixed conductive and sensorineural hearing loss

0.00

-0.00

0.0

1.2

—

Divergent concomitant strabismus

0.00

-0.00

0.0

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

0.00

-0.00

0.0

1.1

—

Haemangioma and lymphangioma, any site

0.00

-0.00

0.0

1.1

—

Atypical facial pain

0.00

-0.00

0.0

1.2

—

Agranulocytosis

0.00

-0.00

0.0

1.1

—

Collagenous colitis

0.00

-0.00

0.0

1.2

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.2

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.2

—

Hordeolum and other deep inflammation of eyelid

0.00

-0.00

0.0

1.2

—

Ménière disease

0.00

-0.00

0.0

1.2

—

Haemangioma, any site

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.2

—

Myocardial infarction, strict

0.00

-0.00

0.0

1.0

—

COPD related to multimorbidity

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.2

—

Other disorders of cornea

0.00

-0.00

0.0

1.2

—

Other embolism and thrombosis

0.00

-0.00

0.0

1.1

—

Chronic periodontitis, including avohilmo

0.98

-0.00

1.0

1.3

—

Hypertension

0.94

-0.00

1.0

1.3

—

Viral meningitis

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of breast, HER-negative

0.00

-0.00

0.0

1.2

—

Helminthiases

0.00

-0.00

0.0

1.2

—

Other disorders of bladder

0.00

-0.00

0.0

1.2

—

Explicit bacterial Sepsis

0.00

-0.00

0.0

1.2

—

Early onset COPD

0.00

-0.00

0.0

1.1

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Listeria sp Ab [Titer] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS